OJ

Orion D. Jankowski

EP Edison Pharmaceuticals: 11 patents #2 of 24Top 9%
BT Bioelectron Technology: 3 patents #6 of 14Top 45%
PT Ptc Therapeutics: 3 patents #65 of 160Top 45%
TC Tyco Electronics Co.: 3 patents #352 of 1,364Top 30%
PH Pharmacyclics: 2 patents #61 of 113Top 55%
Stanford University: 1 patents #115 of 519Top 25%
Overall (All Time): #182,243 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
11840497 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Kieron E. Wesson, Paul Mollard, William D. Shrader 2023-12-12
11312697 Process for the production of alpha-tocotrienol and derivatives Kieron E. Wesson, Andrew W. Hinman 2022-04-26
10968166 4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Kieron E. Wesson, Paul Mollard, William D. Shrader 2021-04-06
10167251 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Kieron E. Wesson, Paul Mollard, William D. Shrader 2019-01-01
10071978 Process for the production of alpha-tocotrienol and derivatives Kieron W. Wesson, Andrew W. Hinman 2018-09-11
9932286 Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Guy M. Miller, Sidney Hecht, Kieron E. Wesson, Paul Mollard 2018-04-03
9546132 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Kieron E. Wesson, Paul Mollard, William D. Shrader 2017-01-17
9278085 Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers Guy M. Miller, Sidney Hecht, Kieron E. Wesson, Paul Mollard 2016-03-08
9169196 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Kieron E. Wesson, Paul Mollard, William D. Shrader 2015-10-27
9090576 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases Andrew W. Hinman, Kieron E. Wesson, William D. Shrader, Edgar P. LEE 2015-07-28
9073873 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases Andrew W. Hinman, Kieron E. Wesson 2015-07-07
8716486 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases Andrew W. Hinman, Kieron E. Wesson 2014-05-06
8716527 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases Andrew W. Hinman, Kieron E. Wesson, Paul Mollard, William D. Shrader, Christopher R. Cornell 2014-05-06
8575369 Process for the production of alpha-tocotrienol and derivatives Kieron E. Wesson, Andrew W. Hinman 2013-11-05
8519001 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Kieron E. Wesson, Paul Mollard, William D. Shrader 2013-08-27
8106223 Process for the production of alpha-tocotrienol and derivatives Kieron E. Wesson, Andrew W. Hinman 2012-01-31
8067395 Inhibitors of tyrosine kinases and uses thereof James T. Palmer, Lee Honigberg 2011-11-29
7968746 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases Kieron E. Wesson, Paul Mollard, William D. Shrader 2011-06-28
7625880 Inhibitors of tyrosine kinases and uses thereof James T. Palmer, Lee Honigberg 2009-12-01
7151116 Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells Paul A. Wender, Elie Amine Tabet 2006-12-19
6987440 Electrical devices containing conductive polymers Paul N. Becker, Cecilia Walsh 2006-01-17
6593843 Electrical devices containing conductive polymers Paul N. Becker, Cecilia Walsh 2003-07-15
6531950 Electrical devices containing conductive polymers Paul N. Becker, James A. Rinde, Barry C. Mathews, Cecilia Walsh 2003-03-11